WHO says it will continue its rollout of AstraZenca vaccine, downplaying concerns

Primary tabs

WHO says it will continue its rollout of AstraZenca vaccine, downplaying concerns

Tue, 2021-03-16 20:08 — mike kraft

WHO: Vaccine rollout unaffected by concerns over AstraZeneca The U.N. health agency says its global rollout of coronavirus vaccines remains unaffected even as a growing number of countries have suspended use of AstraZeneca’s vaccine amid concerns about blood clots in some people who received it Jamey Keaten | AP Washington Post

GENEVA — The U.N. health agency said its global rollout of coronavirus vaccines remains unaffected even as a growing number of countries, especially in Europe, suspended use of AstraZeneca’s vaccine on Monday amid concerns about blood clots in some people who received it.

The World Health Organization says the AstraZeneca vaccines for its COVAX program, which is shipping vaccines mostly to low- and middle-income countries, are being produced in India and South Korea — and the suspensions have been ordered over batches made in Europe.

“We understand these are precautionary measures,” WHO assistant director-general Mariangela Simao said. “I would like to say this to countries from other regions that are not Europe: That the vaccines (at issue) so far are from European manufacturing not vaccines that are provided through the COVAX facility.”

Germany, France, Italy and Spain joined the growing list of mostly European countries — starting with Denmark last week — that temporarily halted use of the AstraZeneca vaccine in recent days to investigate cases of blood clots that occurred after vaccination. Others include Thailand and Congo.

“This does not necessarily mean these events are linked to vaccination,” WHO Director-General Tedros Adhanom Ghebreyesus told a news conference. “But it is routine practice to investigate them and it shows that the surveillance system works and that effective controls are in place.”

While the AstraZeneca product is just one of several vaccines being deployed in Europe, the vaccine has a huge role so far in COVAX. The program began shipments in late February and has plans to ship more than 200 million doses by the end of May — nearly all of them versions of the Oxford-AstraZeneca vaccine. ...

ALSO SEE: Sweden is latest country to stop using AstraZeneca vaccine

Country / Region Tags:

Africa

Democratic Republic of the Congo